Answer
Women taking Riamet (artemether + lumefantrine) should not breastfeed during treatment and should not resume until at least one week after the last dose unless potential benefits to mother and child outweigh the risks of Riamet treatment.
Sources for this answer
- Riamet 20/120mg tabletsNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 30Document updated
Sources checked